Isolation and Characterization of Murine Monoclonal Antibodies Specific for Gram-negative Bacterial Lipopolysaccharide: Association of Cross-genus Reactivity with Lipid A Specificity
Overview
Affiliations
Somatic cell hybrids secreting monoclonal antibodies against the core-glycolipid portion of enterobacterial endotoxin were derived from mice immunized with Escherichia coli J5 or Salmonella minnesota R595 heat-killed organisms or lipopolysaccharide (LPS). Eight antibodies were selected for their ability to cross-react with several members of a panel of gram-negative bacterial antigens in a radioimmunoassay. This panel represented five genera and two families of organisms: E. coli O111:B4, E. coli O55:B5, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella minnesota, and Serratia marcescens. The binding sites for six of the antibodies were unequivocally localized within the lipid A moiety of the endotoxin molecule by using the radioimmunoassay on LPS and free lipid A. The anti-lipid A antibodies were further characterized for their ability to interact with LPS variants by using a sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunostaining procedure. The monoclonal antibodies bound almost exclusively to the low-molecular-weight species of LPS on the polyacrylamide gel. These components corresponded to LPS isolated from rough strains of organisms (strains which lack O-specific carbohydrate). These results suggested that the cross-reactive component of antisera raised against rough mutants of gram-negative bacteria contain antibodies of lipid A specificity. Moreover, the determinant within the lipid A moiety of LPS may have been accessible to the monoclonal antibodies only in those endotoxin molecules on the outer membrane surface which lack the O-specific carbohydrate.
Delpino M, Estein S, Fossati C, Baldi P Clin Vaccine Immunol. 2007; 14(10):1296-301.
PMID: 17715332 PMC: 2168122. DOI: 10.1128/CVI.00459-06.
Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.
Salomao R, Rigato O, Pignatari A, Freudenberg M, Galanos C Infection. 1999; 27(1):1-11.
PMID: 10027099 DOI: 10.1007/BF02565163.
Brade L, Engel R, Christ W, Rietschel E Infect Immun. 1997; 65(9):3961-5.
PMID: 9284181 PMC: 175568. DOI: 10.1128/iai.65.9.3961-3965.1997.
Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.
Frasa H, Tavares L, van Kessel K, Hustinx W, Schellekens J, Kraaijeveld K Antimicrob Agents Chemother. 1996; 40(4):999-1004.
PMID: 8849267 PMC: 163246. DOI: 10.1128/AAC.40.4.999.
Mascelli M, Frederick B, Ely T, Neblock D, Shealy D, Pak K Infect Immun. 1993; 61(5):1756-63.
PMID: 8478065 PMC: 280762. DOI: 10.1128/iai.61.5.1756-1763.1993.